SCI

May 2024

Prediction of tumor origin in cancers of unknown primary origin with cytology-based deep learning

(Nature medicine;IF:82.9)

  • Tian F, Liu D, Wei N, Fu Q, Sun L, Liu W, Sui X, Tian K, Nemeth G, Feng J, Xu J, Xiao L, Han J, Fu J, Shi Y, Yang Y, Liu J, Hu C, Feng B, Sun Y, Wang Y, Yu G, Kong D, Wang M, Li W, Chen K, Li X. Prediction of tumor origin in cancers of unknown primary origin with cytology-based deep learning. Nat Med. 2024 Apr 16. doi: 10.1038/s41591-024-02915-w. Epub ahead of print. PMID: 38627559.

  • These authors contributed equally: Fei Tian, Dong Liu, Na Wei, Qianqian Fu, Lin Sun, Wei Liu, Xiaolong Sui. e-mail: liwencai@zzu.edu.cn; chenkexin@tmu.edu.cn; lixiangchun@tmu.edu.cn

Abstract 摘要

Cancer of unknown primary (CUP) site poses diagnostic challenges due to its elusive nature. Many cases of CUP manifest as pleural and peritoneal serous effusions. Leveraging cytological images from 57,220 cases at four tertiary hospitals, we developed a deep-learning method for tumor origin differentiation using cytological histology (TORCH) that can identify malignancy and predict tumor origin in both hydrothorax and ascites. We examined its performance on three internal (n = 12,799) and two external (n = 14,538) testing sets. In both internal and external testing sets, TORCH achieved area under the receiver operating curve values ranging from 0.953 to 0.991 for cancer diagnosis and 0.953 to 0.979 for tumor origin localization. TORCH accurately predicted primary tumor origins, with a top-1 accuracy of 82.6% and top-3 accuracy of 98.9%. Compared with results derived from pathologists, TORCH showed better prediction efficacy (1.677 versus 1.265, P < 0.001), enhancing junior pathologists' diagnostic scores significantly (1.326 versus 1.101, P < 0.001). Patients with CUP whose initial treatment protocol was concordant with TORCH-predicted origins had better overall survival than those who were administrated discordant treatment (27 versus 17 months, P = 0.006). Our study underscores the potential of TORCH as a valuable ancillary tool in clinical practice, although further validation in randomized trials is warranted.

原发部位不明癌症(CUP)因其难以捉摸的性质而面临诊断挑战。许多病例表现为胸膜和腹膜浆液性积液。利用来自四家三级医院的 57,220 例病例的细胞学图像,我们开发了一种使用细胞组织学 (TORCH) 进行肿瘤起源区分的深度学习方法,该方法可以识别恶性肿瘤并预测胸水和腹水的肿瘤起源。我们对其在三个内部测试集(n=12,799)和两个外部测试集(n=14,538)上的性能进行了评估。在内部和外部测试集中,TORCH的受试者工作曲线下面积值范围为0.953至0.991,用于癌症诊断,肿瘤起源定位为0.953至0.979。TORCH准确预测原发肿瘤起源,其前1名预测准确率为82.6%,前3名预测准确率为98.9%。与病理学家的结果相比,TORCH显示出更好的预测效果(1.677 vs 1.265,P < 0.001 ),显著提高了初级病理学家的诊断得分(1.326 vs 1.101,P < 0.001)。初始治疗方案与TORCH预测的起源一致的CUP患者比接受不一致治疗的患者具有更好的总生存期(27个月 vs 17个月,P=0.006)。尽管需要进一步进行随机试验验证,但我们认为本次实验强调了TORCH作为临床实践有价值辅助工具这一潜力。